MRK Message Board Post 9266790 | Merck & Company Inc. (new)
home / stock / mrk / mrk message board
humbleinvestor
(investorshub)
Posted on: Feb/02/2023 13:10:56
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=171098554
$MRK 4Q22 results2023 guidance:
News, Short Squeeze, Breakout and More Instantly...
-
On Sunday, Pfizer (NYSE: PFE) and AstraZeneca Plc (NASDAQ: AZN) were among the pharmaceutical companies who announced they will be investing a...
-
New Phase 3 data evaluating sacituzumab tirumotecan (sac-TMT), an investigational TROP2-directed antibody-drug conjugate, in previously treated locally recurrent or metastatic triple-negative breast cancer First presentation of Phase 2b three-year follow-up data evaluating mRNA-4157 (V940...
-
Merck (NYSE: MRK) announced that it is discontinuing a cohort of the phase III study evaluating a co-formulation of its blockbuster PD-L1 inhibitor...